Biogen Posts Higher Q2 Earnings, But Sales Miss Views

By: via Benzinga
Biogen Inc (NASDAQ: BIIB) reported better-than-expected earnings for the second quarter, but the company's revenue missed analysts' ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.